Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.19.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
CURRENT ASSETS    
Cash and cash equivalents $ 667 $ 161
Accounts receivable 691 777
Other current assets 536 553
Current assets of discontinued operations 24,660 23,421
Total current assets 26,554 24,912
FIXED ASSETS, net of accumulated depreciation 634 497
OTHER ASSETS    
Operating lease right-of-use assets 153  
Restricted cash 350 350
Patents and other intangible assets, net of accumulated amortization 3,126 3,349
Investment in joint venture 92 92
Goodwill 5,963 5,963
Other 243 243
Total other assets 9,927 9,997
Total Assets 37,115 35,406
CURRENT LIABILITIES    
Accounts payable and accrued expenses 2,777 3,100
Obligations under operating leases, current portion 207  
Obligations under finance leases, current portion 36  
Obligations under finance leases, current portion   20
Deferred revenue 1,622 1,215
Convertible note, net 3,101 2,481
Advance from NovellusDx, Ltd., net 1,500 535
Other derivatives 0 86
Current liabilities of discontinued operations 22,665 20,742
Total current liabilities 31,908 28,179
Obligations under finance leases, less current portion 140  
Obligations under finance leases, less current portion   23
Obligations under operating leases, less current portion 78  
Deferred rent payable and other 0 154
Warrant liability 49 248
Total Liabilities 32,175 28,604
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ EQUITY    
Preferred stock, authorized 9,764 shares, $0.0001 par value, none issued 0 0
Common stock, authorized 100,000 shares, $0.0001 par value, 57,816 and 27,726 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively 6 3
Additional paid-in capital 171,021 164,455
Accumulated other comprehensive income 19 60
Accumulated deficit (166,106) (157,716)
Total Stockholders’ Equity 4,940 6,802
Total Liabilities and Stockholders’ Equity $ 37,115 $ 35,406